// App-Quantinova.ai

6048 : Racial disparity in oncologic and patient-reported quality of life (PROs) outcomes in patients with locally advanced head and neck squamous cell carcinomas (HNSCC) enrolled in a randomized phase II trial.

Researchers

Presenter

  • Margaret Winn Kendrick

Principal Investigators

  • Mary Weber Redman

  • Kelsey K. Baker

  • Renato G. Martins

  • Keith D. Eaton

  • Laura Quan Man Chow

  • Rafael Santana-Davila

  • Christina S. Baik

  • Bernardo H. L. Goulart

  • Sylvia Mina Lee

  • Cristina P. Rodriguez

Medical Centers

  • Seattle Cancer Care Alliance/University of Washington, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

Biomarkers

  • N/A

Drug/Treatment

  • Erlotinib hydrochloride

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved